...
首页> 外文期刊>Internal medicine. >Sirs score reflects clinical features of non-acetaminophen-related acute liver failure with hepatic coma
【24h】

Sirs score reflects clinical features of non-acetaminophen-related acute liver failure with hepatic coma

机译:Sirs评分反映了非对乙酰氨基酚相关的急性肝衰竭伴昏迷的临床特征

获取原文
获取原文并翻译 | 示例

摘要

Objective In acetaminophen-induced acute liver failure (ALF), the hepatic coma grade worsens and mortality rates increase, as the number of systemic inflammatory response syndrome components fulfilled (SIRS score) increases. This study aimed to investigate the impact of SIRS score on clinical features of non-acetaminophen-related ALF. Methods Ninety-nine patients with non-acetaminophen-related ALF with hepatic coma who did not undergo liver transplantation were investigated. Each patient was given a SIRS score of 0, 1, 2, 3 or 4 at the time of diagnosis. Results At the diagnosis of ALF with hepatic coma, with the increase of SIRS score, hepatic coma grade and prothrombin activity were deteriorated. After the diagnosis of ALF with hepatic coma, 25 patients (25%) developed acute respiratory distress syndrome (ARDS), 31 patients (31%) developed disseminated intravascu-lar coagulation (DIC), and 21 patients (22%) developed acute renal failure (ARF). Thirty-eight patients (38%) developed MOF. With the increase of SIRS score, frequencies of the development of ARDS, DIC and MOF increased. ARF was more frequently developed in patients with a SIRS score of 2 or higher. Overall, 36 patients (36%) survived. Overall survival rate was 66% in 29 patients with a score of 0, 43% in 21 patients with a score of 1, 17% in 29 patients with a score of 2 and 15% in 20 patients with a score of 3 or 4. Conclusion SIRS score will be useful for predicting not only the overall survival but also the development of complications such as ARDS, DIC and MOF in non-acetaminophen-related ALF with hepatic coma.
机译:目的在对乙酰氨基酚引起的急性肝功能衰竭(ALF)中,随着系统性炎症反应综合征组成部分(SIRS评分)的实现,肝昏迷程度恶化,死亡率增加。本研究旨在调查SIRS评分对非对乙酰氨基酚相关ALF临床特征的影响。方法对99例未进行肝移植的非对乙酰氨基酚相关性ALF伴有肝昏迷的患者进行调查。在诊断时,每位患者的SIRS评分均为0、1、2、3或4。结果在诊断为ALF伴肝昏迷时,随着SIRS评分的升高,肝昏迷分级和凝血酶原活性均下降。在诊断为ALF并伴有肝昏迷后,有25例患者(25%)出现了急性呼吸窘迫综合征(ARDS),31例患者(31%)出现了弥散性血管内凝血(DIC),21例患者(22%)出现了急性肾故障(ARF)。 38名患者(38%)发生了MOF。随着SIRS分数的增加,ARDS,DIC和MOF的发生频率增加。 SIRS评分为2或更高的患者更常发生ARF。总体而言,有36名患者(36%)存活了下来。 29例患者的总生存率为66%,得分为0,21例患者的总生存率为43%,得分为1,17例患者的总生存率为2,得分为2,15%的患者,总体得分为3或4。结论SIRS评分不仅可用于预测非对乙酰氨基酚相关的ALF并伴有肝昏迷的总生存期,而且可预测诸如ARDS,DIC和MOF等并发症的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号